Skip to main content
Clinical Trials/NL-OMON22733
NL-OMON22733
Completed
Not Applicable

Efficacy and safety of home treatment versus in hospital treatment with LMWH in patients with non-massive pulmonary embolism

eiden University Medical Center, Department of General Internal Medicine-Endocrinology0 sites260 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary embolismHome treatmentLow-molecular-weight-heparinAnd in Dutch: LongembolieThuisbehandelingLaag-moleculair-gewicht-heparine
Sponsor
eiden University Medical Center, Department of General Internal Medicine-Endocrinology
Enrollment
260
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
eiden University Medical Center, Department of General Internal Medicine-Endocrinology

Eligibility Criteria

Inclusion Criteria

  • 1\. Consecutive patients with proven acute non\-massive, stable Pulmonary Embolism (PE), i.e. PE that does not warrant thrombolytic therapy, presenting to the emergency ward or to the outpatient clinic.
  • 2\. Patients with provoked and non\-provoked (‘idiopathic’) pulmonary embolism and patient with a first as well as those with a recurrent episode of pulmonary embolism are considered eligible for the study.

Exclusion Criteria

  • 1\. Patients who have had symptoms of PE for longer than 7 days duration
  • 2\. Active bleeding, or a very high risk for major bleeding, i.e. gastro\-intestinal bleeding in the preceding 14 days, recent stroke (less than 4 weeks ago), recent operation (less than 2 weeks ago), bleeding disorder, or thrombocytopenia (platelet count \< 75 x 109/L)

Outcomes

Primary Outcomes

Not specified

Similar Trials